Module 18 - Drug Device Combinations and Other Technologies

05/12/2023

Medicated TDS: What are the safety considerations?

• Target organ toxicity • Local toxicity • Degradant/impurity profile

The Organisation for Professionals in Regulatory Affairs

25

Medicated TDS: What are the safety considerations?

• Target organ toxicity - No • Local toxicity - No

• Degradant/impurity profile – Different profile of leachables/extractables (related to patch adhesive)

The Organisation for Professionals in Regulatory Affairs

26

13